• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

器官移植受者中肺囊虫肺炎的暴发和聚集:系统评价。

Outbreaks and clustering of Pneumocystis pneumonia in kidney transplant recipients: a systematic review.

机构信息

Department of Infectious Diseases, Leiden University Medical Center, the Netherlands.

出版信息

Med Mycol. 2011 Oct;49(7):673-80. doi: 10.3109/13693786.2011.571294. Epub 2011 Apr 1.

DOI:10.3109/13693786.2011.571294
PMID:21453224
Abstract

From 1980 onwards, an increasing number of outbreaks of Pneumocystis pneumonia (PCP) among kidney transplant recipients have been reported. The cause of these outbreaks is unclear and different explanations have been provided. We performed a systematic review to provide a comprehensive overview of the epidemiologic characteristics as well as the involved clinical risk factors. A total of 15 peer-reviewed English language articles published from 1980 onward were included. Outbreak settings were all marked by absence of adequate chemoprophylaxis, frequent inter-patient contacts and lack of isolation measures taken during hospitalization of PCP cases. PCP-associated mortality rates significantly decreased from a weighted mean of 38% before 1990 to 19% and 13% in the following two decades. Clinical risk factors for PCP in outbreak settings were largely similar to non-outbreak settings. Genotyping by multilocus sequence typing (MLST) or comparison of the internal transcribed spacer (ITS) regions 1 and 2 showed that the outbreaks are most frequently caused by a predominant or a single Pneumocystis strain. Pooled epidemiological data and genotyping results strongly support the theory that interhuman transmission of Pneumocystis occurred. No seasonal trend was noted. The results emphasize the need for chemoprophylaxis in kidney transplant recipients despite a low baseline incidence of PCP in this population, and support the current CDC recommendation with regard to isolation of patients with PCP during hospitalization.

摘要

自 1980 年以来,越来越多的肾移植受者中出现卡氏肺孢子虫肺炎(PCP)爆发。这些爆发的原因尚不清楚,有不同的解释。我们进行了系统评价,以提供流行病学特征以及涉及的临床危险因素的全面概述。共纳入了 1980 年以来发表的 15 篇同行评审的英文文章。爆发环境的特点是缺乏充分的化学预防、患者之间频繁接触以及在 PCP 病例住院期间缺乏隔离措施。PCP 相关死亡率显著下降,从 1990 年之前的加权平均值 38%下降到随后二十年的 19%和 13%。爆发环境中 PCP 的临床危险因素与非爆发环境中相似。多位点序列分型(MLST)或内部转录间隔区 1 和 2 的比较基因分型显示,爆发最常由主要或单一的卡氏肺孢子虫菌株引起。汇总的流行病学数据和基因分型结果强烈支持人与人之间传播卡氏肺孢子虫的理论。未观察到季节性趋势。结果强调了肾移植受者需要进行化学预防的必要性,尽管该人群中 PCP 的基线发病率较低,并支持目前疾病预防控制中心关于在住院期间隔离 PCP 患者的建议。

相似文献

1
Outbreaks and clustering of Pneumocystis pneumonia in kidney transplant recipients: a systematic review.器官移植受者中肺囊虫肺炎的暴发和聚集:系统评价。
Med Mycol. 2011 Oct;49(7):673-80. doi: 10.3109/13693786.2011.571294. Epub 2011 Apr 1.
2
Systematic review of outbreaks of Pneumocystis jirovecii pneumonia: evidence that P. jirovecii is a transmissible organism and the implications for healthcare infection control.耶氏肺孢子菌肺炎暴发的系统评价:耶氏肺孢子菌是一种可传播病原体的证据及其对医疗保健机构感染控制的影响
J Hosp Infect. 2016 May;93(1):1-8. doi: 10.1016/j.jhin.2016.01.018. Epub 2016 Feb 10.
3
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.用于治疗肾移植受者中已存在的和新发糖尿病的降糖药物。
Cochrane Database Syst Rev. 2017 Feb 27;2(2):CD009966. doi: 10.1002/14651858.CD009966.pub2.
4
Health professionals' experience of teamwork education in acute hospital settings: a systematic review of qualitative literature.医疗专业人员在急症医院环境中团队合作教育的经验:对定性文献的系统综述
JBI Database System Rev Implement Rep. 2016 Apr;14(4):96-137. doi: 10.11124/JBISRIR-2016-1843.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV-infection.辅助性皮质类固醇用于HIV感染患者的耶氏肺孢子菌肺炎
Cochrane Database Syst Rev. 2006 Jul 19(3):CD006150. doi: 10.1002/14651858.CD006150.
7
Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.纤维素、改性纤维素和合成膜在终末期肾病患者血液透析中的比较。
Cochrane Database Syst Rev. 2001(3):CD003234. doi: 10.1002/14651858.CD003234.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
9
Physical interventions to interrupt or reduce the spread of respiratory viruses.物理干预措施以阻断或减少呼吸道病毒的传播。
Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6.
10
Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients.用于治疗肾移植受者急性排斥反应的多克隆抗体和单克隆抗体。
Cochrane Database Syst Rev. 2017 Jul 20;7(7):CD004756. doi: 10.1002/14651858.CD004756.pub4.

引用本文的文献

1
pneumonia in thoracic organ transplantation: Current perspectives and updates.胸器官移植中的肺炎:当前观点与进展
JHLT Open. 2025 Aug 7;10:100367. doi: 10.1016/j.jhlto.2025.100367. eCollection 2025 Nov.
2
Metabolic modelling as a powerful tool to identify critical components of Pneumocystis growth medium.代谢建模作为一种强大的工具,可用于鉴定卡氏肺孢子虫生长培养基的关键成分。
PLoS Comput Biol. 2024 Oct 28;20(10):e1012545. doi: 10.1371/journal.pcbi.1012545. eCollection 2024 Oct.
3
Slicing through the challenge of maintaining in the laboratory.
突破在实验室中维持……的挑战。(原句“maintaining”后缺少内容,翻译可能不太准确,仅供参考)
mBio. 2024 Mar 13;15(3):e0327723. doi: 10.1128/mbio.03277-23. Epub 2024 Feb 12.
4
Outbreaks of Fungal Infections in Hospitals: Epidemiology, Detection, and Management.医院内真菌感染的暴发:流行病学、检测与管理
J Fungi (Basel). 2023 Oct 29;9(11):1059. doi: 10.3390/jof9111059.
5
Catestatin: Antimicrobial Functions and Potential Therapeutics.抑胃肽:抗菌功能与潜在疗法
Pharmaceutics. 2023 May 20;15(5):1550. doi: 10.3390/pharmaceutics15051550.
6
Risk factors and outcomes of Pneumocystis pneumonia in solid organ transplant recipients: Impact of posttransplant lymphoproliferative disorder.实体器官移植受者中肺孢子菌肺炎的风险因素和结局:移植后淋巴组织增生性疾病的影响。
Clin Transplant. 2023 Sep;37(9):e15021. doi: 10.1111/ctr.15021. Epub 2023 May 17.
7
Analysis of Pneumocystis Transcription Factor Evolution and Implications for Biology and Lifestyle.肺炎克雷伯菌转录因子进化分析及其对生物学和生活方式的影响。
mBio. 2023 Feb 28;14(1):e0271122. doi: 10.1128/mbio.02711-22. Epub 2023 Jan 18.
8
Belatacept Use after Kidney Transplantation and Its Effects on Risk of Infection and COVID-19 Vaccine Response.肾移植后使用贝拉西普及其对感染风险和新冠疫苗反应的影响。
J Clin Med. 2021 Nov 3;10(21):5159. doi: 10.3390/jcm10215159.
9
Genetic and Epidemiologic Analyses of an Outbreak of Pneumocystis jirovecii Pneumonia Among Kidney Transplant Recipients in the United States.美国一起肾移植受者肺孢子菌肺炎暴发的遗传与流行病学分析。
Clin Infect Dis. 2022 Mar 1;74(4):639-647. doi: 10.1093/cid/ciab474.
10
Application of metagenomic next-generation sequencing in the diagnosis and treatment guidance of Pneumocystis jirovecii pneumonia in renal transplant recipients.宏基因组二代测序在肾移植受者肺孢子菌肺炎诊断和治疗指导中的应用。
Eur J Clin Microbiol Infect Dis. 2021 Sep;40(9):1933-1942. doi: 10.1007/s10096-021-04254-x. Epub 2021 Apr 21.